Caricamento...

A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93

With over eight million cases of tuberculosis each year there is a pressing need for the development of new vaccines against Mycobacterium tuberculosis. Subunit vaccines consisting of recombinant proteins are an attractive vaccine approach due to their inherent safety compared to attenuated live vac...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Orr, Mark T., Beebe, Elyse A., Hudson, Thomas E., Moon, James J., Fox, Christopher B., Reed, Steven G., Coler, Rhea N.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2014
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3880254/
https://ncbi.nlm.nih.gov/pubmed/24404140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0083884
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !